Rivoceranib + Paclitaxel
NCT05905887
Asan Medical Center · Phase 2 · Recruiting · Enrollment 48
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Rivoceranib + Paclitaxel
Asan Medical Center · Phase 2 · Recruiting · Enrollment 48
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.